Pharmagest Ebitda from 2010 to 2026
| PHF Stock | EUR 34.85 17.92 33.96% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 79.4 M | Current Value 59.6 M | Quarterly Volatility 13.8 M |
Check Pharmagest Interactive financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagest Interactive's main balance sheet or income statement drivers, such as Tax Provision of 8.8 M, Net Interest Income of 2.7 M or Discontinued Operations of 108.6 K, as well as many indicators such as . Pharmagest financial statements analysis is a perfect complement when working with Pharmagest Interactive Valuation or Volatility modules.
Pharmagest | Ebitda |
The Ebitda trend for Pharmagest Interactive SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmagest Interactive is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pharmagest Interactive's Ebitda Growth Pattern
Below is the plot of the Ebitda of Pharmagest Interactive SA over the last few years. It is Pharmagest Interactive's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmagest Interactive's overall financial position and show how it may be relating to other accounts over time.
| Ebitda | 10 Years Trend |
|
Ebitda |
| Timeline |
Pharmagest Ebitda Regression Statistics
| Arithmetic Mean | 51,868,623 | |
| Geometric Mean | 50,257,210 | |
| Coefficient Of Variation | 26.61 | |
| Mean Deviation | 12,113,674 | |
| Median | 45,450,000 | |
| Standard Deviation | 13,801,456 | |
| Sample Variance | 190.5T | |
| Range | 39.4M | |
| R-Value | 0.88 | |
| Mean Square Error | 44.8T | |
| R-Squared | 0.78 | |
| Slope | 2,413,333 | |
| Total Sum of Squares | 3047.7T |
Pharmagest Ebitda History
About Pharmagest Interactive Financial Statements
Pharmagest Interactive stakeholders use historical fundamental indicators, such as Pharmagest Interactive's Ebitda, to determine how well the company is positioned to perform in the future. Although Pharmagest Interactive investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmagest Interactive's assets and liabilities are reflected in the revenues and expenses on Pharmagest Interactive's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmagest Interactive SA. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBITDA | 79.4 M | 59.6 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Pharmagest Stock
Pharmagest Interactive financial ratios help investors to determine whether Pharmagest Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagest with respect to the benefits of owning Pharmagest Interactive security.